Evolva Competitors

Delisted . USA . 
Stock . Evolva Holding SA
ELVAFDelisted Stock  USD 0.90  0.00  0.00%   
Evolva Holding SA competes with Finch Therapeutics, Starpharma Holdings, Celyad Oncology, Avicanna, and Positron Corp; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Evolva Holding competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Evolva Holding to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Evolva Holding vs Positron Corp Correlation

Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.900.900.90
Details
Intrinsic
Valuation
LowRealHigh
0.770.770.99
Details
Naive
Forecast
LowNextHigh
0.900.900.90
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.900.900.90
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evolva Holding. Your research has to be compared to or analyzed against Evolva Holding's peers to derive any actionable benefits. When done correctly, Evolva Holding's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evolva Holding SA.

Evolva Holding Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Evolva Holding and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Evolva and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Evolva Holding SA does not affect the price movement of the other competitor.

High positive correlations

MRES
+ 0.7
CLYYF
AVCNF
+ 0.52
CLYYF
AVCNF
+ 0.4
MRES
POSC
+ 0.4
VYYRF
POSC
+ 0.39
SPHRF
MRES
+ 0.22
FNCH
  

High negative correlations

CLYYF
- 0.76
SPHRF
MRES
- 0.58
SPHRF
AVCNF
- 0.51
SPHRF
POSC
- 0.41
CLYYF
AVCNF
- 0.36
RVXCF
POSC
- 0.32
RVXCF

Risk-Adjusted Indicators

There is a big difference between Evolva Pink Sheet performing well and Evolva Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evolva Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
FNCH  1.29  0.08  0.01  0.79  1.51 
(1.95)
 3.21 
(3.43)
 8.64 
RVXCF  3.55  0.31  0.02 (0.63) 5.03 
(10.93)
 14.29 
(12.50)
 34.29 
SPHRF  2.11  1.07  0.00 (1.97) 0.00 
 0.00 
 0.00 
 0.00 
 34.70 
BBIXF  31.24  16.29  0.00 (2.53) 0.00 
 0.00 
 0.00 
 0.00 
 1,000.00 
CLYYF  0.81 (0.40) 0.00  1.06  0.00 
 0.00 
 0.00 
 0.00 
 16.67 
MRES  14.11  1.05  0.06  0.42  15.16 
(24.55)
 47.22 
(28.21)
 111.97 
VYYRF  31.88  14.68  0.00  3.57  0.00 
 0.00 
 15.79 
 0.00 
 1,023 
HSITF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AVCNF  4.12  0.13  0.01  0.42  4.72 
(7.55)
 11.11 
(5.88)
 26.76 
POSC  4.14  0.20  0.02 (0.36) 5.24 
(5.35)
 11.27 
(10.37)
 27.56 

Evolva Holding Competitive Analysis

The better you understand Evolva Holding competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Evolva Holding's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Evolva Holding's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ELVAF FNCH RVXCF SPHRF BBIXF CLYYF MRES VYYRF HSITF AVCNF
 0.00 
 0.90 
Evolva
 0.63 
 14.29 
Finch
 2.71 
 0.07 
Resverlogix
 3.45 
 0.28 
Starpharma
 0.00 
 0.08 
Bonus
 0.00 
 0.15 
Celyad
 17.31 
 0 
Institute
 23.08 
 0.10 
Voyageur
 0.00 
 0.12 
Hadasit
 6.25 
 0.17 
Avicanna
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Very steady
Out of control
Market Performance
(90 Days Performance)
Weakest
Soft
Soft
Solid
Fair
Weakest
Mild
Fair
Weakest
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Strong
Risky
Low
Moderate
High
Low
Moderate
Hazard
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Hold
Not Rated
Strong Sell
Current Ratio
2.02
7.28
0.14
5.93
9.13
0.97
N/A
0.34
17.73
0.9
Net Asset
156.17 M
71 M
9.98 M
66.17 M
104.32 M
79.94 M
5.28 M
2.57 M
66.41 M
22.3 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(31.82 M)
(32.48 M)
(22.93 M)
(16.63 M)
(88.03 M)
(24.73 M)
N/A
(2.05 M)
28.67 M
(15.13 M)
Operating Margin
-2.31
N/A
N/A
-3.13
N/A
N/A
N/A
N/A
N/A
-2.11
Current Valuation
96.17 M
10.74 M
36.3 M
123.62 M
48.99 M
11.81 M
198.84 K
5.74 M
(988.32 K)
20.15 M
Price To Book
0.55
0.14
N/A
4.36
4.05
5.05
0.69
4.11
0.72
9.32
Retained Earnings
(149 M)
(350.39 M)
N/A
(154 M)
N/A
N/A
(55.58 M)
N/A
(125 M)
N/A
Current Asset
73 M
N/A
N/A
50 M
N/A
N/A
2.56 M
N/A
38 M
N/A
Beta
0.71
0.46
0.52
0.85
1.4
1.76
1.71
0.9
0.58
1.94
Number Of Employees
62
1
22
50
4
95
2
10
2
124
Shares Outstanding
1.11 B
1.61 M
265.27 M
408.92 M
1.17 B
22.59 M
66.28 M
132.7 M
11.09 M
74.52 M
Cash Flow From Operations
(29.79 M)
(31.5 M)
(8.02 M)
(13.16 M)
(39.84 M)
(26.64 M)
2.06 M
(1.65 M)
(2.1 M)
(11.66 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.15
N/A
Total Debt
12.35 M
30.13 M
53.27 M
4 M
N/A
2.87 M
N/A
25.52 K
N/A
415.83 K
Return On Equity
-0.37
-0.63
N/A
-0.29
-0.55
-0.93
N/A
-0.77
-0.44
-1.69
Z Score
4.8
N/A
-6.6
21.2
N/A
0.6
-14.0
N/A
-1.4
33.0
Return On Asset
-0.11
-0.22
-0.96
-0.14
-0.0636
-0.29
N/A
-0.38
-0.0296
-0.22
Book Value Per Share
0.1
11.86
-0.23
0.12
N/A
1.36
N/A
0.017
0.98
0.038
Number Of Shares Shorted
N/A
19.2 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
6 M
N/A
N/A
10 M
N/A
N/A
3.8 M
N/A
4 M
N/A
Total Asset
156.17 M
71 M
9.98 M
66.17 M
104.32 M
79.94 M
5.28 M
2.57 M
66.41 M
22.3 M
Debt To Equity
0.11
0.35
N/A
0.17
0.15
0.15
N/A
0.032
0.002
0.31
Short Ratio
N/A
0.19
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
90.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
25.03
11.35
N/A
44.65
0.09
24.19
N/A
N/A
N/A
N/A
Market Capitalization
100.38 M
1.94 M
42.39 M
161.85 M
62.59 M
5.65 M
639.61 K
9.93 M
8.32 M
22.99 M
Price To Earning
-4.94
N/A
11.36
46.82
N/A
N/A
N/A
N/A
1.23
N/A
Price To Earnings To Growth
N/A
-0.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
8.58
30.46
N/A
28.59
N/A
24222.06
N/A
N/A
1381.33
4.51
Net Income
(41.27 M)
(74.75 M)
(24.77 M)
(16.15 M)
(90.08 M)
(26.51 M)
564.67 K
(2.05 M)
28.36 M
(16.77 M)
Earnings Per Share
-0.048
-6.59
-0.11
-0.031
N/A
-1.51
N/A
-0.017
0.61
-0.26
Shares Owned By Insiders
0.66
53.48
44.51
6.1
49.72
8.83
N/A
14.29
74.99
22.52
Revenue
9.88 M
107 K
N/A
4.68 M
N/A
N/A
1.41 M
N/A
N/A
3.27 M
Working Capital
67 M
21.76 M
N/A
40 M
N/A
N/A
N/A
N/A
34 M
N/A
Cash And Equivalents
7.4 M
104.67 M
42 K
49.92 M
N/A
6.1 M
N/A
247.78 K
15.02 M
685.94 K
Cash Per Share
0.01
2.19
N/A
0.12
N/A
0.39
N/A
N/A
1.36
0.01
Gross Profit
(8.81 M)
(57.03 M)
N/A
(9.29 M)
N/A
5 K
N/A
N/A
35.09 M
2.83 M
Day Typical Price
0.9
14.24
0.0719
0.28
0.08
0.15
0.004
0.1
0.12
0.17
Accumulation Distribution
N/A
5.4
N/A
N/A
N/A
N/A
6954.23
N/A
N/A
558.82
Market Facilitation Index
N/A
3.0E-4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0
Daily Balance Of Power
0.0
0.6429
9.2 T
0
0.0
0.0
(1.12)
0
0.0
1.0
Period Momentum Indicator
N/A
0.09
0.0019
(0.01)
N/A
N/A
(0.0009)
(0.03)
N/A
0.01
Rate Of Daily Change
1.0
1.01
1.03
0.97
1.0
1.0
0.83
0.77
1.0
1.06
Day Median Price
0.9
14.22
0.0719
0.28
0.08
0.15
0.0039
0.1
0.12
0.17
Price Action Indicator
N/A
0.11
0.001
(0.01)
N/A
N/A
(0.00005)
(0.01)
N/A
0.01
Coefficient Of Variation
N/A
1854.54
2316.12
487.96
793.73
(579.00)
1775.79
846.96
N/A
3477.74
Mean Deviation
N/A
1.29
3.55
2.11
31.24
0.8073
14.11
31.88
N/A
4.12
Jensen Alpha
N/A
0.0839
0.3108
1.07
16.29
(0.40)
1.05
14.68
N/A
0.1319
Total Risk Alpha
N/A
(0.08)
(0.35)
0.5603
4.1
(0.65)
(0.84)
3.12
N/A
(0.39)
Sortino Ratio
N/A
0.0102
0.0158
N/A
N/A
N/A
0.0555
N/A
N/A
0.0114
Downside Variance
N/A
5.3
179.41
N/A
N/A
N/A
452.15
N/A
N/A
60.36
Standard Deviation
N/A
1.89
6.73
5.11
125.99
2.41
22.37
126.83
N/A
5.82
Kurtosis
N/A
0.3658
2.06
23.99
63.0
37.14
3.35
61.5
N/A
0.173
Potential Upside
N/A
3.21
14.29
N/A
N/A
N/A
47.22
15.79
N/A
11.11
Treynor Ratio
N/A
0.7934
(0.63)
(1.97)
(2.53)
1.06
0.4242
3.57
N/A
0.4242
Maximum Drawdown
N/A
8.64
34.29
34.7
1000.0
16.67
111.97
1023.08
N/A
26.76
Variance
N/A
3.56
45.29
26.13
15873.02
5.82
500.23
16086.82
N/A
33.85
Market Risk Adjusted Performance
N/A
0.8034
(0.62)
(1.96)
(2.52)
1.07
0.4342
3.58
N/A
0.4342
Risk Adjusted Performance
N/A
0.0456
0.0405
0.1586
0.1022
(0.12)
0.0509
0.0964
N/A
0.0298
Skewness
N/A
0.0387
(0.08)
4.8
7.94
(6.03)
1.22
7.79
N/A
(0.06)
Semi Deviation
N/A
1.51
5.03
N/A
N/A
N/A
15.16
N/A
N/A
4.72
Information Ratio
N/A
0.0124
0.0315
0.1896
0.1254
(0.21)
0.0528
0.1175
N/A
0.0153
Value At Risk
N/A
(3.43)
(12.50)
N/A
N/A
N/A
(28.21)
N/A
N/A
(5.88)
Expected Short fall
N/A
(1.95)
(10.93)
N/A
N/A
N/A
(24.55)
N/A
N/A
(7.55)
Downside Deviation
N/A
2.3
13.39
N/A
N/A
N/A
21.26
N/A
N/A
7.77
Semi Variance
N/A
2.28
25.33
N/A
N/A
N/A
229.81
N/A
N/A
22.29

Evolva Holding Competition Performance Charts

Five steps to successful analysis of Evolva Holding Competition

Evolva Holding's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Evolva Holding SA in relation to its competition. Evolva Holding's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Evolva Holding in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Evolva Holding's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Evolva Holding SA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Evolva Holding position

In addition to having Evolva Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Music and Video Thematic Idea Now

Music and Video
Music and Video Theme
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 10 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Evolva Pink Sheet

If you are still planning to invest in Evolva Holding SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evolva Holding's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY